CN1123144A - 3-取代-2-羟基吸吲哚作为病毒复制抑制剂 - Google Patents

3-取代-2-羟基吸吲哚作为病毒复制抑制剂 Download PDF

Info

Publication number
CN1123144A
CN1123144A CN95115291A CN95115291A CN1123144A CN 1123144 A CN1123144 A CN 1123144A CN 95115291 A CN95115291 A CN 95115291A CN 95115291 A CN95115291 A CN 95115291A CN 1123144 A CN1123144 A CN 1123144A
Authority
CN
China
Prior art keywords
salts
pharmaceutical acceptable
thienyl
acceptable bases
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95115291A
Other languages
English (en)
Chinese (zh)
Inventor
桑德拉·L·西尔伯曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1123144A publication Critical patent/CN1123144A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN95115291A 1994-08-17 1995-08-16 3-取代-2-羟基吸吲哚作为病毒复制抑制剂 Pending CN1123144A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29213894A 1994-08-17 1994-08-17
US08/292,138 1994-08-17

Publications (1)

Publication Number Publication Date
CN1123144A true CN1123144A (zh) 1996-05-29

Family

ID=23123389

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95115291A Pending CN1123144A (zh) 1994-08-17 1995-08-16 3-取代-2-羟基吸吲哚作为病毒复制抑制剂

Country Status (8)

Country Link
JP (1) JPH0859464A (ja)
KR (1) KR960006923A (ja)
CN (1) CN1123144A (ja)
AU (1) AU2859495A (ja)
CA (1) CA2156120A1 (ja)
HU (1) HUT73810A (ja)
IL (1) IL114891A0 (ja)
ZA (1) ZA956831B (ja)

Also Published As

Publication number Publication date
CA2156120A1 (en) 1996-02-18
JPH0859464A (ja) 1996-03-05
HUT73810A (en) 1996-09-30
IL114891A0 (en) 1995-12-08
AU2859495A (en) 1996-02-29
KR960006923A (ko) 1996-03-22
ZA956831B (en) 1997-02-17
HU9502420D0 (en) 1995-10-30

Similar Documents

Publication Publication Date Title
CN114191552B (zh) 抗新型冠状病毒SARS-CoV-2的药物及其应用
AU716821B2 (en) Method to improve the biological and antiviral activity of protease inhibitors
Johanson Pseudomonas infections of the foot following puncture wounds
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
Lang et al. Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins
JPH10139668A (ja) ウイルス感染の治療におけるジデオキシヌクレオシドアナローグの使用
JP2024519988A (ja) ５－ニトロ－８－ヒドロキシキノリンの使用
US4853409A (en) 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
JPS63310819A (ja) 抗レトロウイルス活性をもつ糖タンパク処理抑制剤
EP0337627B1 (en) 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
EP0610444B1 (en) Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases
McKinlay et al. Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice
CN1148190C (zh) 用于免疫调节的药物组合物
CN1123144A (zh) 3-取代-2-羟基吸吲哚作为病毒复制抑制剂
Mielens et al. Acute peri-articular inflammation induced in rats by oral 6-sulfanilylindazole
WO1992003130A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
US5519028A (en) Antiviral preparations
Shore et al. Osteolytic lesions in secondary syphilis
KR100227125B1 (ko) 미포자충감염을치료하기위한벤즈이미다졸구충제의용도
Nethercott et al. Azathioprine therapy in incomplete Behcet syndrome
US6455555B1 (en) Anti-HIV infection agents and method for treating HIV infection
US5672610A (en) Methods of increasing macrophage function
CN1071572C (zh) 使用2－氨基嘌呤衍生物治疗和预防人类疱疹病毒7感染
US5192790A (en) 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis
KR100718030B1 (ko) 변형성 관절증 치료제

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication